Drug profile

The FDA adverse-event record for Sucralfate

1,220 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Sucralfate. See the species affected, top reactions, and outcomes below.

1,220
adverse-event reports
25.2%
death-coded share
Dog
most-reported species
349
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,220
Total Reports
307
Deaths Reported
25.2%
Death Rate

Active Ingredients

Sucralfate

Administration Routes

UnknownOralIntravenousRectalSubcutaneousOphthalmicTopical

Species Affected

Dog 898
Horse 247
Cat 70
Parrot 2
Human 1
Ferret 1
Mule 1

Most Affected Breeds

Retriever - Labrador 180
Quarter Horse 59
Domestic Shorthair 48
Retriever - Golden 47
Thoroughbred 43
Horse (unknown) 38
Warmblood (unspecified) 36
Terrier - Yorkshire 35
Chihuahua 31
Terrier - Bull - American Pit 25

Most Reported Reactions

Vomiting 349
Lethargy (see also Central nervous system depression in 'Neurological') 248
Anorexia 226
Lack of efficacy - NOS 218
Diarrhoea 194
Death by euthanasia 185
Other abnormal test result NOS 178
Elevated alanine aminotransferase (ALT) 161
Elevated serum alkaline phosphatase (SAP) 141
Leucocytosis NOS 137
Anaemia NOS 128
Weight loss 116

Outcome Breakdown

Ongoing
462 (37.8%)
Outcome Unknown
243 (19.9%)
Recovered/Normal
206 (16.9%)
Euthanized
187 (15.3%)
Died
121 (9.9%)
Recovered with Sequela
2 (0.2%)

Sucralfate Adverse Event Insights

1,220 reports name Sucralfate; 307 recorded a death outcome (25.2% of reported events, not a population-level mortality rate). Active ingredient: Sucralfate. Administration routes: Unknown, Oral, Intravenous, Rectal.

By species: Dog (898 reports), Horse (247 reports), Cat (70 reports). By breed: Retriever - Labrador (180), Quarter Horse (59), Domestic Shorthair (48).

Leading clinical signs: Vomiting (349), Lethargy (see also Central nervous system depression in 'Neurological') (248), Anorexia (226), Lack of efficacy - NOS (218). Outcome, 1,221 coded reports: Ongoing leads at 37.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.